✦ LIBER ✦

Anti-inflammatory therapy in Alzheimer’s disease: is hope still alive?

✍ Scribed by W. A. van Gool; P. S. Aisen; P. Eikelenboom

Publisher: Springer
Year: 2003
Tongue: English
Weight: 310 KB
Volume: 250
Category: Article
ISSN: 0340-5354
DOI: 10.1007/s00415-003-1146-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-inflammatory agents in Alzheimer’s

Anti-inflammatory agents in Alzheimer’s disease

✍ Paul S. Aisen 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 192 KB

Microglia Activation and Anti-inflammato

Microglia Activation and Anti-inflammatory Regulation in Alzheimer’s Disease

✍ Lih-Fen Lue; Yu-Min Kuo; Thomas Beach; Douglas G. Walker 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 628 KB

Is anti-TNF switching in refractory Stil

Is anti-TNF switching in refractory Still’s disease safe and effective?

✍ Nadia Emi Aikawa; Ana Cristina de Medeiros Ribeiro; Carla Gonçalves Schain Saad; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 110 KB

Anti-TNFα therapy in a rare case of Croh

Anti-TNFα therapy in a rare case of Crohn's disease: still a Panacea

✍ Robert Verburg; Pierre Zelissen; Aniki MD; PhD Rothova; Peter D. Siersema; Bas O 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 1 views

Switching cholinesterase inhibitor thera

Switching cholinesterase inhibitor therapy in Alzheimer's disease—donepezil to rivastigmine, is it worth it?

✍ Roger Bullock; Claire Connolly 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB 👁 1 views

Switching from donepezil to rivastigmine was bene®cial in cognitive and global terms in 55.0% of the patients with Alzheimer's disease studied. \* Side-effects on donepezil and rivastigmine were independent of one another. \* It may be possible to extend the positive effects that cholinesterase inhi